# Role of FGF-23 as a Prognosis Biomarker in Intensive Care Patients

> **NCT01801501** · — · COMPLETED · sponsor: **University of Chile** · enrollment: 164 (actual)

## Conditions studied

- Sepsis
- Acute Kidney Injury

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01801501
- **Lead sponsor:** University of Chile
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2014-04
- **Final completion:** 2018-12
- **Target enrollment:** 164 (ACTUAL)
- **Last updated:** 2020-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01801501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01801501, "Role of FGF-23 as a Prognosis Biomarker in Intensive Care Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01801501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*